Bioscience
Verdosome introduces the COVID Pod for virus testing
WHEAT RIDGE -- Verdosome announced the introduction of its COVID Pod ™ technology for the testing of SARS-CoV-2, the virus that causes COVID-19. COVID Podstands for " COllection Via... Read More
Thursday July 2, 2020 0 comments
CSU: Using cellular networks to detect at-risk areas for spread of COVID
FORT COLLINS -- In the fight against COVID-19, researchers at Colorado State University have developed a new, non-invasive strategy to identify areas at greatest risk for spreading the... Read More
Thursday July 2, 2020 0 comments
Crestone secures NIH funding for development through phase 1 of novel antibiotic candidate
BOULDER -- Crestone, Inc. today announced a contract award from the National Institutes of Health for the advancement of its antibiotic candidate CRS0540 to treat infections caused by... Read More
Wednesday July 1, 2020 0 comments
CSU secures award from U.S. government for development of SolaVAX vaccine manufacturing process for SARS-CoV-2
FORT COLLINS -- A team of infectious disease researchers at Colorado State University has entered into an agreement with the Biomedical Advanced Research and Development Authority ... Read More
Friday June 26, 2020 0 comments
MBio Diagnostics and BARDA partner on 5-minute, quantitative POC COVID-19 antibody panel
BOULDER -- MBio Diagnostics today announced it has been awarded a$629,595contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant... Read More
Wednesday June 24, 2020 0 comments
ArcherDX and Invitae combine to create global leader in comprehensive cancer genetics and precision oncology
BOULDER and SAN FRANCISCO– ArcherDX ,a leading genomics analysis company democratizing precision oncology, and San Francisco-based Invitae (NYSE: NVTA), a leading genetics company, today... Read More
Monday June 22, 2020 0 comments
Ampio to begin first clinical trial in COVID-19 program
ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it is developing therapies for patients infected with the SARS-CoV-2 virus ("COVID-19"). The U.S. Food and Drug... Read More
Monday June 22, 2020 0 comments
ArcherDX collaborates with Bristol Myers Squibb to apply personalized cancer monitoring to clinical research
BOULDER -- ArcherDX, Inc . announced it is entering into a collaboration with Bristol Myers Squibb (BMS) to utilize Personalized Cancer Monitoring (PCM) assays to understand the potential benefits... Read More
Friday June 19, 2020 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
